|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
71,325 |
|
Indirect Shares
|
7,447 |
|
|
Direct
Value |
$26,276,609 |
|
|
Indirect Value
|
$3,536,953 |
|
|
Total
Shares |
78,772 |
|
|
Total
Value |
$29,813,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-05-07 |
4 |
AS |
$52.13 |
$3,062,638 |
D/D |
(58,750) |
31,108 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-02-11 |
4 |
AS |
$243.53 |
$3,216,311 |
D/D |
(13,070) |
46,198 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-07-19 |
4 |
AS |
$161.00 |
$3,220,000 |
D/D |
(20,000) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-12 |
4 |
AS |
$85.00 |
$3,225,000 |
D/D |
(37,500) |
28,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-09-30 |
4 |
OE |
$33.28 |
$3,244,925 |
D/D |
86,000 |
124,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2023-08-10 |
4 |
AS |
$350.00 |
$3,510,850 |
D/D |
(10,031) |
58,814 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-03-29 |
4 |
OE |
$37.86 |
$3,576,273 |
D/D |
80,500 |
179,835 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-05 |
4 |
AS |
$265.72 |
$3,606,232 |
D/D |
(13,356) |
35,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-06-01 |
4 |
AS |
$125.00 |
$3,812,500 |
D/D |
(30,500) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-06-24 |
4 |
AS |
$98.03 |
$4,141,768 |
D/D |
(42,250) |
38,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-04 |
4 |
OE |
$86.52 |
$4,942,968 |
D/D |
43,752 |
78,855 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-05 |
4 |
AS |
$80.65 |
$5,030,805 |
D/D |
(61,907) |
28,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-01-19 |
4 |
AS |
$157.67 |
$5,125,400 |
D/D |
(32,422) |
39,163 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-10-31 |
4 |
AS |
$142.40 |
$5,802,084 |
D/D |
(40,000) |
50,710 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2019-02-11 |
4 |
AS |
$179.44 |
$6,319,216 |
D/D |
(35,095) |
40,165 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2017-03-29 |
4 |
AS |
$106.30 |
$8,664,568 |
D/D |
(80,500) |
99,335 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2014-09-30 |
4 |
AS |
$111.33 |
$9,690,570 |
D/D |
(86,000) |
38,671 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-04 |
4 |
AS |
$258.59 |
$11,475,179 |
D/D |
(43,752) |
35,103 |
0 |
% |
|
193 Records found
|
|
Page 8 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|